Women's Health Clinical Trials
Here are the 6 most popular medical studies in Women's Health Clinical Trials
Anti-tumor antibiotic
Chemotherapy for Triple Negative Breast Cancer
Recruiting3 awardsPhase 2
New Brunswick, New Jersey
This trial is testing a new combination chemotherapy treatment for breast cancer patients with no estrogen receptors, progesterone receptors, or large amounts of human epidermal growth factor receptor 2 (HER2)/neu protein (triple negative).
CDK4/6 Inhibitor
Abemaciclib +1 More for Breast Cancer
Recruiting1 awardPhase 1
New Brunswick, New Jersey
This trial aims to test the safety and feasibility of using a combination of radiation therapy and CDK4/6 inhibitors before surgery in patients with a certain type of breast cancer. The goal is to see
Procedure
Hysterectomy and Weight Loss Surgery for Endometrial Cancer
Recruiting1 award5 criteria
Boston, Massachusetts
This trial is testing whether an expedited referral process for obese endometrial cancer or EIN patients from their gynecologic oncologist to the Brigham Center for Metabolic and Bariatric Surgery can help them have surgery within 8 weeks.
Behavioural Intervention
Serious Game Intervention for Breast and Gynecologic Cancers
Recruiting1 award6 criteria
Pittsburgh, Pennsylvania
This trial is testing whether the game can teach self-advocacy skills to women with metastatic breast or advanced gynecologic cancer, which may help them manage their quality of life concerns and cancer- and treatment-related symptoms.
Popular filter options for Women's Health Clinical Trials trials
Phase 3 Clinical Trials
View 97 phase 3 medical studies.
Monoclonal Antibodies
Pembrolizumab + Chemoradiotherapy for Cervical Cancer
Recruiting1 awardPhase 3
Los Angeles, California
This trial will compare the effectiveness of two cancer treatments for locally advanced cervical cancer. The first treatment is pembrolizumab plus concurrent chemoradiotherapy and the second is placebo plus concurrent chemoradiotherapy. The study's primary hypotheses are that pembrolizumab plus concurrent chemoradiotherapy is superior to placebo plus concurrent chemoradiotherapy with respect to progression-free survival and overall survival.
View More Women's Health Clinical Trials Trials
See another 79 medical studies focused on Women's Health Clinical Trials.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.